Eyevensys is a startup based in France, most recent round Series B, 3 tracked investors.
Eyevensys is a startup founded in 2011 based in France. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Eyevensys is a clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, utilizing an electrotransfection system to deliver DNA plasmids encoding therapeutic proteins into the ciliary muscle to sustainably treat major eye diseases such as wet age-related macular degeneration and geographic atrophy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.